“Finally the first injection in a Dutch arm”, headlines the country’s leading newspaper, Telegraaf, while a dose of the precious Pfizer / BioNTech vaccine was administered on Wednesday January 6 to Sanna Elkadiri, a 39-year-old caregiver in a retirement home in the town of Veghel (south). “We are here at the beginning of the end of the crisis, it is an incredible moment”, said Health Minister Hugo de Jonge.
A symbolic departure
The government had to bring this symbolic event forward by two days under pressure from the public, which does not accept being the last member state of the European Union to launch its vaccination campaign. “I am really disappointed that we were doing this two weeks after the other countries” Europeans, Prime Minister Marc Rutte admitted to parliamentarians.
→ READ. Covid-19: European regulator approves Moderna vaccine
The Netherlands, unlike France, does not face a problem of vaccine acceptability. Among health workers, 80% are candidates for injection. In contrast, the government was not enough « agile » in the distribution of the product, according to the Minister of Health, Hugo de Jonge. The Hague simply hadn’t counted on Pfizer / BioNTech as the first vaccine to hit the market. The logistical organization for this treatment, which requires storage at – 70 ° C, was not there.
Don’t toast the steps
On Monday January 4, the doses ended up arriving in the trauma department of ten hospitals, to be distributed throughout the country. In just two days, 59,608 people (primarily caregivers) have already made an appointment, according to the National Institute of Public Health and the Environment.
From January 18, the health authorities are betting on a rate of 66,000 nursing staff vaccinated each week. But there is also a rule of caution: there is no question of administering en masse a first injection without guaranteeing the possibility of receiving the second dose 28 days later. It will therefore be necessary to wait until the end of February before starting to obtain attractive protection in health establishments. From March, it will be the turn of the over 60s living at home to receive their first dose.
A strategy over several months
The government knows it well, it is not a sprint but a long-distance race that is beginning, and the two days ahead of the national calendar will fundamentally not change much, nor will the 15 days late in some European countries. Peter Rottier, professor emeritus in Virology at the University of Utrecht, confirms that the seasonal effect will play at least as much as the treatment, to reverse the trend. “In three months, everyone will be much better, but first of all, a long and hard winter awaits us”, he underlines in the daily Algemeen Dagblad.
→ READ. In Germany, vaccination is not going as fast as hoped
Since mid-December, the Dutch have been living in strict confinement, with residents called to stay at home and all schools and non-essential stores closed. They should not benefit excessively from the Moderna vaccine (80 million doses reserved across the EU) which has just been approved by the European Medicines Agency. It is only in the spring that the other vaccines, those of AstraZenaca and Janssen, are expected en masse in the Netherlands, which have just passed the mark of 11,000 deaths for 17 million inhabitants.
Language is a lousy traitor. Sometimes it makes us say things that we didn’t really want to say, but that we might think exactly like that. And the unsaid word often has just as much effect as the spoken one.
Friedrich Merz has known what we’re talking about since Saturday morning at the latest. In his application speech for the party leadership of the CDU, his own words struck him twice in the back.
On the one hand, there is the transition that reminded even well-meaning observers of a scene from the comedy series “Stromberg”: “Even those who are socially weak find a heart and care with us. In this context, let me say a word about women. “
You don’t even know what would be worse: If Merz automatically associates women with the socially disadvantaged. Or when it seems natural to him to locate terms like “heart” and “affection” especially in women. Things didn’t get any better when Merz then cited as proof of his friendliness towards women that his wife and daughters could still take it with him.
Top jobs of the day
Find the best jobs now and be notified by email.
The passage in Merz’s speech, in which he rightly cited the development of the corona vaccine as evidence of German innovative strength, was similarly telling. He praised Curevac co-founder Ingmar Hoerr, “who made the discovery 20 years ago that made the vaccine against corona possible. That is a sensational development. That is Germany.”
What Merz did not say: That it was the Turkish couple Ugur Sahin and Özlem Türeci who launched the first corona vaccine with their Mainz company Biontech. Aren’t the two of them Germany? Of course, Merz would probably answer. But apparently not so natural that he would mention them in his speech.
Insight into a subconscious worldview
Merz gave us an insight into his subconscious worldview through his language. A world in which the really important things in Germany are done by men named Ingmar or Friedrich. It is, it has to be said so clearly, a world of yesterday.
Not a single word in such a party conference speech is spontaneous. Everything has been tried and tested umpteen times. Didn’t anyone in the Merz team warn the candidate that their own language would give them away? Or was it believed that the majority of party congress delegates secretly yearn for this very world of yesterday? If so, then this calculation did not work out. The majority of the CDU is further than the candidate Merz.
More: Merz offers to take over the Ministry of Economic Affairs
The decision of United Kingdomto use all available doses of Covid-19 vaccines with the aim of immunizing the greatest number of people by delaying the administration of the second dose for up to 12 weeks, instead of the 3 or 4 weeks tested in clinical trials of vaccines, has led some experts to draw attention to the possible risk that this can pose to the effectiveness of vaccines.
Rockefeller University virologist Paul Bieniasz even claimed that this decision was the best way to create a new version resistant to vaccines. Bieniasz and other virologists are concerned that extending the dosing interval may cause
These are not normal times. The Covid-19 pandemic has created an emergency because authorities have not been able to get it under control quickly enough to prevent a global economic shock. Thanks to a remarkable show of strength in epidemiology and medicine, the pandemic will soon be under control.
Various vaccines will be widely available within a year. Meanwhile, however, the virus has wreaked economic damage worse than the post-2008 financial crisis. That calls for a firm economic strategy.
Unfortunately, the measures taken by European politics have brought little benefit. The reasons for this failure can be traced back to the complicated relationship between the central authorities of the EU and its member states. I have long been a proponent of perpetual bonds. These are bonds that never have to be paid back; only the annual interest has to be paid. This may sound like a radical idea to some, but Eternal Bonds have been in use for centuries.
Great Britain issued unlimited bonds, so-called “consols”, in 1752 and later also used unlimited “war bonds” to finance the Napoleonic wars. The United States issued consols in the 1870s. In fact, the first perpetual bonds issued by the Dutch in 1648 to maintain their dikes are still outstanding; however, the annual interest payments on them are so small that hardly anyone knows of their existence.
Top jobs of the day
Find the best jobs now and be notified by email.
Eternal bonds should be introduced now while international interest rates cannot fall any further. This would mean that this advantage would be permanent. They could be introduced gradually to allow financial markets to become familiar with a new financial market instrument. This is not a problem as an undated bond can easily be sold in tranches.
Until recently, I was in favor of the European Union, not the Member States, issuing perpetual bonds. I understand that this is not feasible under the current circumstances. Despite a number of major policy breakthroughs, the EU does not have sufficient tax revenues to deliver the kind of fiscal stimulus that would be needed to deal with the pandemic.
For an effective financial policy to respond to the pandemic, European governments must therefore expand their own room for maneuver. For this reason, individual countries should issue perpetual bonds to finance the cost of fighting Covid-19.
Although not noticed by the general public, the European Central Bank (ECB) has already introduced perpetual bonds. The ECB bought massive amounts of government bonds as part of its quantitative easing program. The experts know that the ECB has no choice but to keep this debt forever.
The ECB has already introduced perpetual bonds
A market sale of the accumulated bonds could cause excessive market turbulence; Forcing governments to buy them back would never be feasible as it would create unimaginable financial bottlenecks. Instead, the bonds owned by the ECB will simply be replaced with newly issued government bonds when they mature. This redeployment could be continued forever. In this way, quantitative easing has effectively turned fixed-term bonds into perpetual debt.
There is a big difference between perpetual bonds issued directly by governments and perpetual debt that comes indirectly. If a European government issues perpetual bonds, it will fix the low interest rates forever. Conversely, if the government issues new traditional bonds to replenish the holdings of maturing ECB bonds, it may have to pay higher interest rates.
Perpetual bonds issued directly by European governments have one more crucial advantage: the process is more democratic. At the moment, perpetual bonds are being created by the ECB, an institution that does not act under direct responsibility towards the electorate of any particular member state.
The ECB is guided by a tight mandate: maintaining long-term price stability in the euro zone. This is not the mandate that should determine the financial policy decisions of European governments in the Covid-19 emergency. They are obliged to their citizens to counter this emergency with all necessary means. This includes issuing perpetual bonds due to their inherent benefits.
More: Government crisis in Italy is delaying urgently needed billions in aid for the economy
SURVEY – The desire to be vaccinated is the strongest among the most vulnerable French people in the face of the virus.
The vaccination campaign is gaining ground, as is consent to the injection. A majority of French people (56%) now want to be protected against Covid-19, according to an Odoxa-Backbone Consulting survey for Le Figaro and Franceinfo. A clear increase (+ 14 points) compared to the pre-Christmas period. In the meantime, the first vaccinations have been carried out in France. And the government has accelerated its strategy by stages, criticized for its slowness by the oppositions, but also by the French – 81% of them believe that the vaccination is not completed in the country.
And immediately:Follow all the Covid news live from Thursday, January 14
The rise of a “Supply policy” Explain “Likely” the reversal of public opinion, according to the president of Odoxa, Gaël Sliman. “The doubts faded from the moment when vaccination was concretely implemented in France, and where it has proven itself on millions of people around the world, he says. It was therefore not necessary to wait for a majority of French people to be for the vaccination to implement it, on the contrary. ”
Fight against mistrust
Among French people still reluctant to take the anti-Covid-19 bite, nearly one in four (23%) cites the proliferation of vaccinations around them as the strongest incentive. A need for more time and more explanations is mentioned by most refractories (27%).
To fight against mistrust, the Prime Minister again presented vaccination as a means “To hope for a gradual exit” of the crisis “By next summer”, at his weekly press conference on Thursday.
The desire to be vaccinated is strongest among the French people most vulnerable to the virus: those over 65 (77%) and over 75 (86%). Among the other categories of the population, men (66%) are more flexible than women (51%), city dwellers (60%) than those in the countryside (47%), and managers (66%) than workers (58%).
The supporters of La République en Marche remain the most voluntary (80%), unlike the supporters of the National Rally (35%), while Marine Le Pen said “Ready” to get vaccinated last Saturday.
As for the introduction of a “vaccine passport” – which would limit access to restaurants, cafes and places of culture to vaccinated people – a proposal put forward by the center-right UDI party, it was rejected by a majority of French people ( 56%). The Minister of Transport also opposed it, refusing to “Compartmentalize the population”.
»SEE ALSO – Why are we slowly vaccinating against Covid-19?
Why are we slowly vaccinating against Covid-19? – Watch on Figaro Live
The bacteria or viruses like the flu that cause pneumonia can spread over large areas of the lung over the course of hours. In an intensive care unit (ICU), these bacteria or viruses are controlled by antibiotics or by the immune system during the first days of the illness.
But according to a study published in “Nature”, COVID-19 pneumonia is different.
Rather than rapidly infecting large regions of the lung, the virus that causes COVID-19 settles in multiple small areas of the lung. It then hijacks the lungs’ own immune cells and uses them to spread through the lung for an extended period of time, days or even weeks, like multiple wildfires raging through a forest. And, as the infection moves slowly through the lung, it leaves damage in its wake and continually fuels fever, and damage to the kidneys, brain, heart, and other organs.
“It is a totally different mechanism,” says Germán Peces Barba, from the Jiménez Díaz Foundation University Hospital and group leader at CIBERES.
“In a sibylline way -says the pulmonologist Rosario Menéndez- it creates foci in the lung that, little by little they are distributed and causing the injury”. This expert from the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) explains that this dissemination of foci produces a «amplifying effect of the inflammatory response that can sometimes lead to so-called respiratory distress which, in the worst case, will require oxygen and mechanical ventilation».
And this ‘different’ mechanism of action, adds Peces Barba, means that this entity has a different prognosis and that some drugs will not work. But, curiously, says Peces Barba, “the mortality of cases of pneumonia due to covid-19 is lower than that of conventional pneumonia.”
Thus, the study shows that mortality among patients on mechanical ventilation due to Covid-19 was lower than that of ventilated patients with regular pneumonia. “People with covid-19 pneumonia are sick for a long time, but the inflammation of the lungs is not as severe as normal pneumonia.”
The severe complications of COVID-19 compared to other pneumonias could be related to the prolonged course of the disease rather than a more serious illness, the study authors say.
The study is very relevant, highlights Dr. Menéndez, a pulmonologist at Hospital La Fe (Valencia), because it is one of the first in which the immune cells of the lungs of patients with COVID-19 pneumonia have been systematically obtained from through bronchoalvelar lavage and compared with cells from patients with pneumonia from other viruses or bacteria.
Specifically, he explains, “they have seen that macrophages – cells of the immune system – are not capable of fighting the virus that uses these cells to live inside and uses it as a ‘trojan‘”. In this way, “the virus spreads throughout the lung generating different foci, visible through imaging tests.”
The data from this work, says the SEPAR pulmonologist, supports the hypothesis that the inflammation and damage persists longer than conventional pneumonia. And that damage, he warns «affects other organs, such as the endothelium -inner layer of blood vessels- and endothelitis -inflammation of the endothelium-, would explain the long-term damage of the disease».
An added problem, the CIBERES pulmonologist points out, is that «we do not have early detection systems or markers to determine which patients with pneumonia are going to get worse, there is no common pattern, and in a few hours they can be complicated.
Fortunately, there are treatments, Menendez points out, “because we have learned over time what works – corticosteroids, remdesivir … – and what does not work – antivirals, hydroxychloroquine … -“. But, he stresses, “we would like to have more antivirals. We have more antibacterials than antivirals.
In the study of «Nature»Researchers have also identified critical new targets for treating severe SARS-CoV-2 pneumonia and reducing its harm. These targets, they write, would be immune cells: macrophages and T cells.We have seen that macrophages, cells in charge of protecting the lung, can become infected with SARS-CoV-2 and help spread the infection through the lung».
For this reason, researchers at Northwestern Medicine University (USA) are testing an experimental drug targeting these targets in patients with COVID-19 pneumonia in an ongoing clinical trial. “The drug inactivates the inflammatory response of these immune cells, which allows the start of the repair process in the injured lung,” they detail in their article.
“Our goal is to turn COVID-19 into a mild illness, comparable to a severe cold,” says study co-author Scott Budinger.
The information in this work is relevant because, according to this team, «this rapidly mutating RNA virus will elude current vaccines», Hence the importance of developing treatments to reduce the severity of covid-19 in those who develop it
People who have had a heart attack or stroke are wondering if they need a coronavirus vaccine. Vaccine developers are confident that vaccination will not harm these patients.
People with all types of cardiovascular risk factors and diseases must be vaccinated to protect themselves and their families from COVID-19, experts from Columbia University in New York said.
The CDC-approved vaccines pose no threat to people with heart disease. Yesterday, January 15, experts from the American Heart Association released a statement urging people with cardiovascular risk factors to cordial have a history of heart attack or stroke get vaccinated “as soon as possible.”
Vaccination is especially important for these patients because people with cardiovascular disease have a higher chance of developing complications from COVID-19. People with heart disease or stroke – or, for that matter, risk factors for heart disease and stroke – are at much greater risk from the virus than from the vaccine, the American Heart Association explained.
Vaccines have side effects, but the risk of complications is extremely low. For example, the FDA-approved Pfizer-BioNTech vaccine has several side effects, including pain at the injection site, fatigue, headache, muscle pain, chills, joint pain, and high fever.
It is also important to note that most coronavirus vaccines under development do not contain live virus, which is a plus for patients with heart disease or other people with weakened immune systems.
The American Heart Association mentioned that vaccines can also be administered safely to people taking blood-thinning medications. In rare cases, the coronavirus vaccine can cause a severe allergic reaction, so people should be monitored for 15-30 minutes after injection.
AGI – “We are working on Johnson & Jonhnson vaccine, which is currently the most advanced ma there they are also other vaccines for which we have started a dialogueand we are ready to start the procedures. “This is what SkyTg24 says to the microphones Marco Cavaleri, head of the Ema vaccination strategy, the European Medicines Agency of the EU for the European evaluation for the evaluation of medicines.
“We are also in contact with the developers of the Russian and Chinese vaccines – continues Cavaleri -, we are also open to discussing with them to see if there are margins and if there is an interest in a European authorization. We are absolutely open “.
For Johnson & Johnson, “if the results of the clinical study are positive – explains Cavaleri – and available quickly, there is scope for reaching an opinion as early as the end of February-March”. For the Italian ReiThera, “we had initial dialogues and we wait to see new data: we are interested in proceeding with this vaccine which is interesting “.
“From leaflet la second dose of Pfizer vaccine is given after three weeks: obviously if you do it a few days later there is no problem and all European countries are oriented to give some flexibility in this sense but it is important that the second dose is administered as close as possible to these three weeks. The longer you wait, the more there is the risk that the subject will not be protected“. To underline this at SkyTg24 is Marco Cavaleri, head of the Ema vaccination strategy.
“I think it is very difficult to arrive before January 29, which is a possible date but not certain”. Marco Cavaleri, head of the Ema vaccination strategy, thus replies to SkyTg24 to a question about ‘green light’ for the Astrazeneca vaccine. “We are working to reach the goal that day – he assures – We are there a lot of data we are evaluating right now and that they are coming to us from the company. The important thing is that we clarify a whole series of aspects related above all to clinical studies. We are convinced that we can stay in these times “.
Despite the progress of vaccination, the government must take measures to counter the evolution of the epidemic.
While the English variant continues its journey in Europe, the executive must decide on new measures. A re-containment or more likely a curfew advanced everywhere in France? End of the suspense tonight at 6 p.m. In China, no hesitation. Faced with the appearance of a few cases near Beijing, the authorities have locked the region. To get out of this nightmare, the vaccination is gaining new momentum with us and expanding its audience. While waiting for thecollective immunity, the clouds are gathering on theschool. Will the government succeed in keeping it open while the majority of European countries have sent children home?
Camille Lestienne, journalist at Le Figaro
1. Curfew in France, blockade in China
Between confinement and curfew, the heart of the executive swings. More than 23,000 new Covid-19 contaminations have been detected in France in 24 hours while 232 deaths are to be deplored. According to experts interviewed by TheFigaro, the English variant should dominate in France in two to three months. “But, in terms of the number of people actually infected, this will depend on compliance with barrier gestures and measures decided to limit its spread ”, warns a researcher. The government will have to make a choice between the different scenarios: status quo, re-containment or, more likely, an extension of the curfew to 6 p.m. at the national level. This decision is expected to be announced this Thursday at 6 p.m. during the traditional press conference of the Prime Minister. A choice more political than epidemiological. “The only measure whose effectiveness is proven is full containment, but it is violent and has very serious implications,” explains an expert. You can understand that the authorities are trying something sweeter. ” For Emmanuel Macron, “in the face of this virus which evolves as living beings evolve“, We must assume changes in strategy”week to week».
Read also :Covid-19: curfew at 6 p.m. Here are the departments where the epidemic is worsening
Read also :“Confinement, curfew: home prison”
Elsewhere, we lock. The English variant is digging its way into Europe. It is a “tsunami” that is hitting the country, in the words of Prime Minister Michael Martin. A “black January”, for Deputy Prime Minister Leo Varadkar. The images are strong as is the resurgence of the epidemic in Ireland. With an infection rate that has quadrupled over the past ten days, the country is on lockdown again as is Portugal re-locked from Friday. On the other side of the globe, China is also mobilizing as the virus reappears in Hebei province near Beijing. Power is sounding the alarm a few weeks before the Chinese New Year. “The stake is political for President Xi Jinping, analyze our correspondent, while the propaganda shows the superiority of the ʺ socialist model with Chinese characteristics ’in the face of the virus.»
The United States is also facing an outbreak of the epidemic with a record 4,500 deaths in 24 hours. From January 26, the presentation of a negative test for Covid-19 will be necessary to travel in the country. But the danger is most often found within borders. Several elected officials announced that they tested positive after being locked up with parliamentarians refusing to wear the mask during the assault on the Capitol.
2. Vaccination is gaining momentum
In France, we vaccinate all the time. The government is putting the turbo on vaccination by opening it to all health professionals over 50 or fragile, as well as home helpers and firefighters. There were 247,000 people vaccinated yesterday, 400,000 should be by the end of the week. Will this be enough to catch up with France’s lag behind other countries? From January 18, people over 75 years of age can also be vaccinated. But how do you make an appointment? Le Figaro explains everything to you. Another challenge: to convince more and more “anti-tax” in France and in all circles. Will they change their minds while elsewhere in Europe criticism is raining on the too slow delivery of vaccines? The orders of vaccine doses pooled by the European Commission are insufficient accuses Germany. The pressure should ease in a few months when other vaccines hit the market. The next is AstraZeneca, which should be authorized by the European Medicines Agency (EMA) on January 29. But doubts remain about its effectiveness in protecting the over 65s.
Read also :Covid-19: will we be able to choose our vaccine?
My intuition is that vaccines will limit the amount of virus produced and the duration of contagiousness.
Odile Launay, Director of the Cochin-Pasteur Clinical Investigation Center in Vaccinology
The vaccination in question. When will vaccination give us herd immunity? Not this year, according to the WHO. In a few months, according to Olivier Véran. But in the face of so much uncertainty, an American study brings us good news. Immunity would be at least eight months for Covid patients. Another question remains: does the vaccine reduce the contagion of the Coronavirus? If the vaccine protects against a severe form of the disease, the virus can eventually travel to the upper respiratory tract and be transmitted. “However, when you don’t get sick, you make fewer viruses for less time. My intuition is therefore that vaccines will limit the amount of virus produced and the duration of contagiousness ”, advances Odile Launay, director of the Cochin-Pasteur clinical investigation center in vaccinology.
Read also :Covid-19: Could a “vaccine passport” to access certain places and services see the light of day in France?
3. School threatened, economy infused
The closure of schools or canteens is worrying. The role of children in the spread of the Covid-19 epidemic is still unclear. After being suspected of being important vectors of the disease as with classic influenza, they were finally cleared before the British variant again shed light on the contagiousness of 12-16 year olds. In France, the incidence rate is also increasing among the youngest and the question of the closure of schools is raised again. This prospect is currently dismissed by the government despite pressure from scientists and teachers’ unions. School canteens, where barrier gestures are difficult to apply, are particularly in the eye of the storm. In the event of closure, it would be a real headache for families. In Europe, many countries have already sent children home. The United Kingdom, of course, struggling with a rebound in the epidemic, but also Germany, the Netherlands, Ireland, Scotland and Sweden. A situation that leaves little hope for French students suffering after months of distancing and isolation.
We will continue to support all economic sectors that are suffering for as long as necessary and at the level which will be useful.
Bruno Le Maire, Minister of the Economy, Finance and Recovery
The economy on a drip. « We will continue to support all economic sectors that are suffering for as long as necessary and at the level which will be useful“, Assured the Minister of the Economy, Bruno Le Maire during his vows. Partial unemployment maintained, strong solidarity fund, relaxation of the repayment of loans guaranteed by the State (PGE), essential emergency aid but which will nevertheless one day have to be eliminated. A thorny issue for the government. Despite this support, the city centers of metropolitan areas are withering away with an ever-increasing number of shops being closed. And advancing a 6 p.m. curfew wouldn’t help their business. Hope is now placed in vaccination, in particular for five sectors: air transport, catering, tourism, the oil sector and culture. For the latter, a reassessment of the situation is scheduled for January 20. “Museums and historic monuments could be structures which, as part of stabilizing the epidemic, could be the subject of a supervised reopening», Indicated Roselyne Bachelot.
Read also :A year without museums or monuments or almost
4. Curfew, instructions for use
Partly deconfined, France is under curfew since December 15. While it is now possible to move around freely during the day, leaving your home is prohibited between 8 p.m. and 6 a.m., under penalty of a fine of 135 euros. In several departments where the virus is circulating more intensely, the curfew is brought forward to 6 p.m.
Read also :Curfew: what is authorized and what remains prohibited from December 15
There are exceptional reasons for which a certificate must be presented.
Consultations and care
Travel for compelling family reasons.
Travel for people with disabilities and their companions.
Judicial or administrative summons.
Participation in missions of general interest
Travel related to transit
Short trips for the needs of pets.
Read also :Curfew: download the certificate on paper or smartphone
5. Reflexes to keep
A few simple actions can limit the spread of the virus. Here they are :
Wash your hands every hour or use hydroalcoholic gel
Cough or sneeze into the crease of your elbow
Use disposable tissues
Avoid kissing or shaking hands
Wear a mask in public spaces when respect for physical distances is not guaranteed.
Covid-19 is transmitted through droplets (respiratory secretions), by close contact with an infected person, especially when the latter coughs or sneezes. But it can also be transmitted through the air. The virus also remains viable for a few hours on different surfaces.
The disease manifests itself in several symptoms. In 9 out of 10 cases, this results in a fever below 39 ° C. According to the World Health Organization, this fever is most often accompanied by fatigue, signs of shortness of breath and a dry cough. Often a loss of smell and taste.
6. What to do in case of symptoms?
The most important thing is to get tested. According to the recommendations of the Ministry of Health, you should, in case of symptoms, stay at home and contact your doctor who will order a test. While waiting for the result, you must isolate yourself, wear a mask and prepare a list of people you could have infected.
If the test is positive, the Primary Health Insurance Fund will contact people likely to be infected. You must then remain isolated for at least 8 days, taking care not to infect your loved ones. Watch your health. In case of fever, take paracetamol. If necessary, schedule a follow-up remote consultation with your doctor. If you feel that you are having difficulty breathing, call 15.
If the test is negative, contact your doctor and follow his instructions.